{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:30:08Z","timestamp":1759048208875,"version":"3.37.3"},"reference-count":49,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2021,6,10]],"date-time":"2021-06-10T00:00:00Z","timestamp":1623283200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["UL1 TR001860"],"award-info":[{"award-number":["UL1 TR001860"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100005825","name":"National Institute of Food and Agriculture","doi-asserted-by":"publisher","award":["#2016-11003 \u201cDual Purpose-Dual Benefit\u201d"],"award-info":[{"award-number":["#2016-11003 \u201cDual Purpose-Dual Benefit\u201d"]}],"id":[{"id":"10.13039\/100005825","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["T32 OD011147\/OD\/NIH"],"award-info":[{"award-number":["T32 OD011147\/OD\/NIH"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Pediatric Emergency Medicine Research Foundation"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:p>Bovine respiratory syncytial virus (RSV) has substantial morbidity in young calves, and closely parallels human RSV in infants. We performed a randomized controlled trial in five to six-week-old Holstein calves (<jats:italic>Bos taurus<\/jats:italic>). comparing fusion protein inhibitor (FPI) and non-steroidal anti-inflammatory drug (NSAID) singly and in combination at three and five days after experimental BRSV infection. Thirty-six calves received one of six treatments; Ibuprofen started on day 3, Ibuprofen started on day 5, FPI started on day 5, FPI and Ibuprofen started on day 3, FPI and Ibuprofen started on day 5, or placebo. We have previously reported significant clinical benefits when combined FPI and NSAID treatment was started at three and five days after bovine RSV infection. Necropsy was performed on Day 10 following infection and hematoxylin and eosin staining was performed on sections from each lobe. Histology was described using a four-point scale. We performed canonical discrimination analysis (CDA) to determine the structural level where differences between treatments occurred and mixed effects regression to estimate effect sizes. Separation from placebo was maximal for dual therapy at the levels of the alveolus, septum, and bronchus in CDA. We found that the clinical benefits of combined FPI and NSAID treatment of BRSV extend at least partially from histopathological changes in the lung when treatment was started three days after infection. We found decreased lung injury when ibuprofen was started as monotherapy on day 3, but not day 5 following infection. Combined therapy with both an FPI and ibuprofen was always better than ibuprofen alone. We did not prove that the clinical benefits seen starting FPI and ibuprofen five days after infection can be solely explained by histopathological differences as identified on H&amp;E staining.<\/jats:p>","DOI":"10.1371\/journal.pone.0252455","type":"journal-article","created":{"date-parts":[[2021,6,10]],"date-time":"2021-06-10T23:58:47Z","timestamp":1623369527000},"page":"e0252455","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":9,"title":["A randomized controlled trial comparing non-steroidal anti-inflammatory and fusion protein inhibitors singly and in combination on the histopathology of bovine respiratory syncytial virus infection"],"prefix":"10.1371","volume":"16","author":[{"given":"Francisco R.","family":"Carvallo Chaigneau","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Walsh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maxim","family":"Lebedev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victoria","family":"Mutua","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heather","family":"McEligot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heejung","family":"Bang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4961-9210","authenticated-orcid":true,"given":"Laurel J.","family":"Gershwin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2021,6,10]]},"reference":[{"issue":"2","key":"pone.0252455.ref001","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1177\/0300985813501341","article-title":"Respiratory syncytial virus infection in cattle","volume":"51","author":"RE Sacco","year":"2014","journal-title":"Vet Pathol"},{"issue":"11","key":"pone.0252455.ref002","doi-asserted-by":"crossref","first-page":"e0142479","DOI":"10.1371\/journal.pone.0142479","article-title":"Single Pathogen Challenge with Agents of the Bovine Respiratory Disease Complex","volume":"10","author":"LJ Gershwin","year":"2015","journal-title":"PLoS One"},{"key":"pone.0252455.ref003","doi-asserted-by":"crossref","first-page":"291","DOI":"10.2460\/ajvr.2000.61.291","article-title":"Bovine respiratory syncytial virus-specific IgE is associated with interleukin-2 and -4, and interferon-gamma expression in pulmonary lymph of experimentally infected calves","volume":"61","author":"LJ Gershwin","year":"2000","journal-title":"Am J Vet Res"},{"issue":"4","key":"pone.0252455.ref004","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1002\/ppul.23570","article-title":"Respiratory syncytial virus hospitalization and mortality: Systematic review and meta-analysis","volume":"52","author":"RT Stein","year":"2017","journal-title":"Pediatr Pulmonol"},{"issue":"1","key":"pone.0252455.ref005","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2012.02.010","article-title":"Determinants of asthma after severe respiratory syncytial virus bronchiolitis","volume":"130","author":"LB Bacharier","year":"2012","journal-title":"J Allergy Clin Immunol"},{"issue":"11\u201312","key":"pone.0252455.ref006","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/S0264-410X(98)80123-0","article-title":"A bovine model of vaccine enhanced respiratory syncytial virus pathophysiology","volume":"16","author":"LJ Gershwin","year":"1998","journal-title":"Vaccine"},{"issue":"02","key":"pone.0252455.ref007","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1017\/S1466252307001405","article-title":"Bovine respiratory syncytial virus infection: immunopathogenic mechanisms","volume":"8","author":"LJ Gershwin","year":"2007","journal-title":"Animal Health Research Reviews"},{"key":"pone.0252455.ref008","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1016\/j.vaccine.2003.10.024","article-title":"Formalin-inactivated bovine RSV vaccine enhances a Th2 mediated immune response in infected cattle","volume":"22","author":"W Kalina","year":"2004","journal-title":"Vaccine"},{"issue":"4","key":"pone.0252455.ref009","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1093\/oxfordjournals.aje.a120954","article-title":"An epidemiologic study of altered clinical reactivity to respiratory syncytial (RS) virus infection in children previously vaccinated with an inactivated RS virus vaccine","volume":"89","author":"AZ Kapikian","year":"1969","journal-title":"Am J Epidemiol"},{"key":"pone.0252455.ref010","first-page":"349","article-title":"Bovine respiratory syncytial virus-specific IgE is associated with interleukin-2 and -4, and interferon-gamma expression in pulmonary lymph of experimentally infected calves","volume":"50","author":"RS Stewart","year":"1989","journal-title":"Am J Vet Res"},{"issue":"4","key":"pone.0252455.ref011","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/0165-2427(89)90077-9","article-title":"Detection of IgE antibodies to bovine respiratory syncytial virus","volume":"20","author":"RS Stewart","year":"1989","journal-title":"Vet Immunol Immunopathol"},{"issue":"4","key":"pone.0252455.ref012","doi-asserted-by":"crossref","first-page":"e0152913","DOI":"10.1371\/journal.pone.0152913","article-title":"A Randomized Placebo Controlled Trial of Ibuprofen for Respiratory Syncytial Virus Infection in a Bovine Model","volume":"11","author":"P Walsh","year":"2016","journal-title":"PLoS One"},{"issue":"6","key":"pone.0252455.ref013","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1586\/14787210.3.6.945","article-title":"Prospects of antiviral and anti-inflammatory therapy for respiratory syncytial virus infection","volume":"3","author":"JC Blanco","year":"2005","journal-title":"Expert review of anti-infective therapy"},{"issue":"9","key":"pone.0252455.ref014","doi-asserted-by":"crossref","first-page":"e0203770","DOI":"10.1371\/journal.pone.0203770","article-title":"Wheezing after the use of acetaminophen and or ibuprofen for first episode of bronchiolitis or respiratory tract infection","volume":"13","author":"P Walsh","year":"2018","journal-title":"PLoS One"},{"issue":"6","key":"pone.0252455.ref015","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1093\/infdis\/162.6.1277","article-title":"Adverse effects of aspirin, acetaminophen, and ibuprofen on immune function, viral shedding, and clinical status in rhinovirus-infected volunteers","volume":"162","author":"NM Graham","year":"1990","journal-title":"J Infect Dis"},{"issue":"3","key":"pone.0252455.ref016","doi-asserted-by":"crossref","first-page":"e0230245","DOI":"10.1371\/journal.pone.0230245","article-title":"A randomized controlled trial of a combination of antiviral and nonsteroidal anti-inflammatory treatment in a bovine model of respiratory syncytial virus infection","volume":"15","author":"P Walsh","year":"2020","journal-title":"PLoS One"},{"issue":"8","key":"pone.0252455.ref017","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1056\/NEJMoa1401184","article-title":"Oral GS-5806 activity in a respiratory syncytial virus challenge study","volume":"371","author":"JP DeVincenzo","year":"2014","journal-title":"N Engl J Med"},{"issue":"8","key":"pone.0252455.ref018","doi-asserted-by":"crossref","first-page":"4889","DOI":"10.1128\/AAC.00487-15","article-title":"Antiviral Efficacy of a Respiratory Syncytial Virus (RSV) Fusion Inhibitor in a Bovine Model of RSV Infection","volume":"59","author":"R Jordan","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"issue":"7","key":"pone.0252455.ref019","doi-asserted-by":"crossref","first-page":"4356","DOI":"10.4049\/jimmunol.174.7.4356","article-title":"Respiratory syncytial virus (RSV) infection induces cyclooxygenase 2: a potential target for RSV therapy","volume":"174","author":"JY Richardson","year":"2005","journal-title":"J Immunol"},{"key":"pone.0252455.ref020","volume-title":"Clinical Epidemiology: How to Do Clinical Practice Research","author":"RB Haynes","year":"2006","edition":"3"},{"issue":"4","key":"pone.0252455.ref021","doi-asserted-by":"crossref","first-page":"473","DOI":"10.2460\/ajvr.1999.60.04.473","article-title":"Evaluation of severe disease induced by aerosol inoculation of calves with bovine respiratory syncytial virus","volume":"60","author":"A Woolums","year":"1999","journal-title":"American journal of veterinary research"},{"issue":"15","key":"pone.0252455.ref022","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1016\/j.vaccine.2017.01.059","article-title":"A recombinant subunit vaccine for bovine RSV and Histophilus somni protects calves against dual pathogen challenge","volume":"35","author":"LJ Gershwin","year":"2017","journal-title":"Vaccine"},{"issue":"5","key":"pone.0252455.ref023","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1080\/00273171.2017.1344538","article-title":"Small Sample Methods for Multilevel Modeling: A Colloquial Elucidation of REML and the Kenward-Roger Correction","volume":"52","author":"D McNeish","year":"2017","journal-title":"Multivariate Behav Res"},{"issue":"5","key":"pone.0252455.ref024","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.vaccine.2016.12.048","article-title":"A single, low dose of a cGMP recombinant BCG vaccine elicits protective T cell immunity against the human respiratory syncytial virus infection and prevents lung pathology in mice","volume":"35","author":"PF C\u00e9spedes","year":"2017","journal-title":"Vaccine"},{"issue":"10","key":"pone.0252455.ref025","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1164\/rccm.2109077","article-title":"Perflubron reduces lung inflammation in respiratory syncytial virus infection by inhibiting chemokine expression and nuclear factor-kappa B activation","volume":"165","author":"HA Haeberle","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"pone.0252455.ref026","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/0264-410X(93)90304-G","article-title":"Lack of detectable enhanced pulmonary histopathology in cotton rats immunized with purified F glycoprotein of respiratory syncytial virus (RSV) when challenged at 3\u20136 months after immunization","volume":"11","author":"SW Hildreth","year":"1993","journal-title":"Vaccine"},{"issue":"5","key":"pone.0252455.ref027","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/0264-410X(90)90253-I","article-title":"Enhanced pulmonary histopathology is observed in cotton rats immunized with formalin-inactivated respiratory syncytial virus (RSV) or purified F glycoprotein and challenged with RSV 3\u20136 months after immunization","volume":"8","author":"BR Murphy","year":"1990","journal-title":"Vaccine"},{"issue":"1","key":"pone.0252455.ref028","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1038\/s41467-018-04216-6","article-title":"Efficacy of a respiratory syncytial virus vaccine candidate in a maternal immunization model","volume":"9","author":"JCG Blanco","year":"2018","journal-title":"Nat Commun"},{"issue":"32","key":"pone.0252455.ref029","doi-asserted-by":"crossref","first-page":"3951","DOI":"10.1016\/j.vaccine.2017.06.009","article-title":"Preclinical assessment of safety of maternal vaccination against respiratory syncytial virus (RSV) in cotton rats","volume":"35","author":"JCG Blanco","year":"2017","journal-title":"Vaccine"},{"key":"pone.0252455.ref030","first-page":"562","volume-title":"Multilevel and Longitudinal Modeling Using Stata","author":"S Rabe-Hesketh","year":"2008","edition":"2"},{"issue":"7556","key":"pone.0252455.ref031","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1136\/bmj.332.7556.1506","article-title":"Is restricted randomisation necessary?","volume":"332","author":"CE Hewitt","year":"2006","journal-title":"BMJ"},{"key":"pone.0252455.ref032","doi-asserted-by":"crossref","first-page":"e5840","DOI":"10.1136\/bmj.e5840","article-title":"Reporting and analysis of trials using stratified randomisation in leading medical journals: review and reanalysis","volume":"345","author":"BC Kahan","year":"2012","journal-title":"Bmj"},{"key":"pone.0252455.ref033","unstructured":"Dahly D. Out of balance A perspective on covariate adjustment in randomized experiments. 10\/4\/2020, 2019."},{"issue":"4","key":"pone.0252455.ref034","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1002\/sim.4780080410","article-title":"Covariate imbalance and random allocation in clinical trials","volume":"8","author":"SJ Senn","year":"1989","journal-title":"Stat Med"},{"issue":"9","key":"pone.0252455.ref035","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1002\/sim.5713","article-title":"Seven myths of randomisation in clinical trials","volume":"32","author":"S Senn","year":"2013","journal-title":"Stat Med"},{"key":"pone.0252455.ref036","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1186\/1745-6215-15-139","article-title":"The risks and rewards of covariate adjustment in randomized trials: an assessment of 12 outcomes from 8 studies","volume":"15","author":"BC Kahan","year":"2014","journal-title":"Trials"},{"key":"pone.0252455.ref037","unstructured":"StataCorp. Stata 16 Multivariate Statistics Reference Manual:. Stata Press; 2019:75\u201382."},{"issue":"2\u20133","key":"pone.0252455.ref038","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1300\/J079v11n02_06","article-title":"Understanding Canonical Discriminant Function. Analysis","volume":"11","author":"C Cocozzelli","year":"1988","journal-title":"Journal of Social Service Research"},{"issue":"3","key":"pone.0252455.ref039","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1080\/00031305.1992.10475889","article-title":"Interpretation of Canonical Discriminant Functions, Canonical Variates, and Principal Components","volume":"46","author":"AC Rencher","year":"1992","journal-title":"The American Statistician"},{"issue":"1","key":"pone.0252455.ref040","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.cellimm.2009.03.007","article-title":"Ibuprofen and other widely used non-steroidal anti-inflammatory drugs inhibit antibody production in human cells","volume":"258","author":"S Bancos","year":"2009","journal-title":"Cell Immunol"},{"issue":"6","key":"pone.0252455.ref041","doi-asserted-by":"crossref","first-page":"3231","DOI":"10.1074\/jbc.272.6.3231","article-title":"Prostaglandin synthase-1 and prostaglandin synthase-2 are coupled to distinct phospholipases for the generation of prostaglandin D2 in activated mast cells","volume":"272","author":"ST Reddy","year":"1997","journal-title":"J Biol Chem"},{"issue":"3","key":"pone.0252455.ref042","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/j.1365-2125.1993.tb05690.x","article-title":"Equipotent inhibition by R(-)-, S(+)- and racemic ibuprofen of human polymorphonuclear cell function in vitro","volume":"35","author":"M Villanueva","year":"1993","journal-title":"Br J Clin Pharmacol"},{"issue":"11","key":"pone.0252455.ref043","doi-asserted-by":"crossref","first-page":"6752","DOI":"10.1016\/S0021-9258(17)39792-2","article-title":"Activation of a 15-lipoxygenase\/leukotriene pathway in human polymorphonuclear leukocytes by the anti-inflammatory agent ibuprofen","volume":"259","author":"JY Vanderhoek","year":"1984","journal-title":"J Biol Chem"},{"issue":"5663","key":"pone.0252455.ref044","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1126\/science.1092385","article-title":"Neutrophil extracellular traps kill bacteria","volume":"303","author":"V Brinkmann","year":"2004","journal-title":"Science"},{"key":"pone.0252455.ref045","article-title":"A Review of Neutrophil Extracellular Traps (NETs) in Disease: Potential Anti-NETs Therapeutics","author":"V Mutua","year":"2020","journal-title":"Clin Rev Allergy Immunol"},{"issue":"6","key":"pone.0252455.ref046","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1136\/thoraxjnl-2017-210289","article-title":"Local dornase alfa treatment reduces NETs-induced airway obstruction during severe RSV infection","volume":"73","author":"B Cortjens","year":"2018","journal-title":"Thorax"},{"issue":"3","key":"pone.0252455.ref047","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1002\/path.4660","article-title":"Neutrophil extracellular traps cause airway obstruction during respiratory syncytial virus disease","volume":"238","author":"B Cortjens","year":"2016","journal-title":"J Pathol"},{"issue":"12","key":"pone.0252455.ref048","doi-asserted-by":"crossref","first-page":"3731","DOI":"10.3390\/v4123731","article-title":"Neonatal calf infection with respiratory syncytial virus: drawing parallels to the disease in human infants","volume":"4","author":"RE Sacco","year":"2012","journal-title":"Viruses"},{"issue":"1","key":"pone.0252455.ref049","article-title":"Utility of the Neonatal Calf Model for Testing Vaccines and Intervention Strategies for Use against Human RSV Infection","volume":"7","author":"M Guerra-Maupome","year":"2019","journal-title":"Vaccines (Basel)"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0252455","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T16:13:47Z","timestamp":1725207227000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0252455"}},"subtitle":[],"editor":[{"given":"Rik L.","family":"de Swart","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2021,6,10]]},"references-count":49,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2021,6,10]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0252455","relation":{},"ISSN":["1932-6203"],"issn-type":[{"type":"electronic","value":"1932-6203"}],"subject":[],"published":{"date-parts":[[2021,6,10]]}}}